stars 1 stars 2 stars 3

CENTERVUE S.p.A. was established in 2008 in Padova. A US subsidiary was opened in 2012. We design and manufacture highly automated, Internet-connected, medical devices for the diagnosis and management of ocular pathologies, including those that represent the leading causes of blindness. CENTERVUE sells its products worldwide in more than 70 countries, has obtained several international patents, and has installed more than 3000 devices as of the end of 2015. 30% of the budget is dedicated every year to the research and development division. CENTERVUE features a completely autonomous structure including research, product development, production, marketing, sales and post-sales departments. The selected management and R&D core team own a multi-year expertise in the development, marketing and sale of computerised ophthalmic devices. Our ambition is to build a bridge between engineering and the health care field by designing breakthrough solutions, and skillfully exploiting knowledge, state-of-the-art technologies, materials and software. Following this purpose, CENTERVUE is now becoming the undiscussed leader in Retinal Imaging Innovation, outlining new and unexplored horizons in the eyecare practice.

CENTERVUE, INC. Questions

The CENTERVUE, INC. annual revenue was $5 million in 2026.

CENTERVUE, INC. is based in Fremont, California.

The NAICS codes for CENTERVUE, INC. are [33].

The SIC codes for CENTERVUE, INC. are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users